Trained immunity versus innate immune tolerance in endometriosis: macrophage memory, lesion persistence, and therapeutic reprogramming

In: Frontiers in Immunology · 2026 · vol. 17 · doi:10.3389/fimmu.2026.1932061 · W7226022222
Review OA: gold CC0

Abstract

Endometriosis affects roughly 10% of women of reproductive age. The defining feature is endometrial-like tissue growing outside the uterus, where it provokes chronic inflammation, fibrosis, and pain. Peritoneal macrophages—normally the cells that clear menstrual debris—become dysfunctional: they accumulate in large numbers, yet their phagocytic capacity is reduced relative to the burden of ectopic tissue, a defect that is multifactorial rather than absolute. Why macrophages settle into these defective states has been unclear. The discovery of trained immunity offers one mechanistic framework. Innate immune cells, including macrophages, can develop a lasting functional memory of prior exposures through epigenetic and metabolic reprogramming. Prior stimulation can produce enhanced responsiveness (trained immunity) or attenuated responses to subsequent challenge (innate immune tolerance); neither outcome necessarily corresponds to a fixed pro- or anti-inflammatory macrophage phenotype. In endometriosis, these two programs have been proposed to exert opposite effects on disease. In a proof-of-concept mouse study, adoptive transfer of BCG-trained macrophages accelerates lesion growth, whereas LPS-tolerized macrophages suppress it—an effect that depends on IL-10 signaling through STAT3 to induce SOCS3 in endometriotic cells. No human study has directly demonstrated trained or tolerized memory in endogenous peritoneal macrophages from patients with endometriosis. Human data are suggestive but retrospective: women with a history of Gram-negative infections (LPS-rich) tend to have milder disease and shorter infertility, while those with Gram-positive infections (which engage TLR2, like BCG) report more pain and more frequent endometriomas; these associations do not demonstrate that microbial products directly imprinted peritoneal macrophages and may be confounded. Single-cell transcriptomics now reveals that endometriotic lesions contain multiple macrophage subsets far beyond the simple M1/M2 binary, and these subsets are shaped by estrogen, extracellular vesicles, DAMPs, and microbial signals. This review draws together the trained immunity and endometriosis literatures to critically evaluate the evidence that pathological macrophage memory contributes to lesion persistence, and to assess whether therapeutically reprogramming this memory—via metabolic modulators like metformin and itaconate derivatives, epigenetic drugs, CD47-SIRPα checkpoint blockade, or nanoparticle-based delivery—could become a non-hormonal treatment strategy; most of these interventions remain untested in endometriosis models.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (57)

Source provenance

openalex
last seen: 2026-11-15T06:03:07.880986+00:00
License: CC0 · commercial use OK